Eli Lilly Obesity Drug Shows Promise in New Study
Eli Lilly's experimental obesity drug, eloralintide, showed it helped people lose substantially more weight when combined with Zepbound, according to a new study.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.